IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss
Portfolio Pulse from
IDEAYA Biosciences, Inc. (IDYA) reported a larger-than-expected loss for Q4, with a loss of $1.49 per share compared to the Zacks Consensus Estimate of $0.67. This is a significant increase from the $0.52 loss per share reported a year ago.
February 13, 2025 | 1:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
IDEAYA Biosciences reported a Q4 loss of $1.49 per share, significantly missing the Zacks Consensus Estimate of $0.67 and increasing from a $0.52 loss per share a year ago.
The reported loss per share of $1.49 is significantly higher than the expected loss of $0.67, indicating worse-than-expected financial performance. This is likely to negatively impact the stock price in the short term as it reflects a deterioration in financial health compared to both the estimate and the previous year's performance.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100